PMID- 11928230 OWN - NLM STAT- MEDLINE DCOM- 20021030 LR - 20061115 IS - 0377-8231 (Print) IS - 0377-8231 (Linking) VI - 156 IP - 5-6 DP - 2001 TI - [Stromelysin-1 in inflammatory disease: significance, specificity, and regulation elements]. PG - 275-81; discussion 281-3 AB - Stromelysin-1 or matrix metalloproteinase-3 (MMP-3) is a key enzyme of the degradation of the extracellular matrix in rheumatoid arthritis. MMP-3 is indeed induced by pro-inflammatory cytokines and may in turn activate other metalloproteinases. MMP-3 is a synovial parameter reflecting the local inflammatory reaction induced by inflammatory cytokines. It is not specific for rheumatoid arthritis nor for the erosive capacity of an arthropathy, which does not exclude its role in articular degradation. Serum MMP-3 is increased in diseases characterized by synovitis but also by steroid therapy. Although it is not disease-specific, serum MMP-3 could be useful as a synovial-derived marker of local inflammation in rheumatoid arthritis, in parallel to CRP which is a systemic marker of inflammation. Furthermore, early determination of serum MMP-3 could constitute a new tool predictive of the disease activity and the therapeutic response in rheumatoid arthritis. FAU - Ribbens, C AU - Ribbens C AD - Universite de Liege, Centre hospitalier universitaire du Sart-Tilman, Service de Rhumatologie, Centre d'Etude des Maladies inflammatoires chroniques. FAU - Malaise, M AU - Malaise M LA - fre PT - English Abstract PT - Journal Article TT - La stromelysine-1 en pathologie inflammatoire: signification, specificite et elements de regulation. PL - Belgium TA - Bull Mem Acad R Med Belg JT - Bulletin et memoires de l'Academie royale de medecine de Belgique JID - 7608462 RN - EC 3.4.24.17 (Matrix Metalloproteinase 3) SB - IM MH - Arthritis, Rheumatoid/*enzymology MH - Humans MH - Matrix Metalloproteinase 3/analysis/*physiology MH - Organ Specificity MH - Synovial Fluid/chemistry/physiology EDAT- 2002/04/04 10:00 MHDA- 2002/11/01 04:00 CRDT- 2002/04/04 10:00 PHST- 2002/04/04 10:00 [pubmed] PHST- 2002/11/01 04:00 [medline] PHST- 2002/04/04 10:00 [entrez] PST - ppublish SO - Bull Mem Acad R Med Belg. 2001;156(5-6):275-81; discussion 281-3.